NL-OMON35742撤回不适用
Feasibility of ultra high field 7.0. Tesla MR Spectroscopy for breast cancer detection and monitoring of neo-adjuvant chemotherapy efficacy - 7T MRS breast cancer study
niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- 18 years or older
- •- Group 1: patients selected for neo-adjuvant chemotherapy
- •- Group 2: patients with BIRADS 4c or 5 classification on mammography, US or lower field MRI, selected for surgery
- •- Group 3: healthy volunteers
排除标准
- •- Any prior surgery or radiotherapy to the ipsilateral breast
- •- Karnofsky score <= 70
- •- Pregnant or lactating women
- •- Contra-indications to MRI scanning according to the 7T screening list of the UMCU
研究者
相似试验
已完成
不适用
Feasibility of ultra high field 7.0 Tesla MR Spectroscopy for monitoring neo-adjuvant therapy efficacy.breast neoplasm10006291breast cancerNL-OMON38209niversitair Medisch Centrum Utrecht15
招募中
不适用
Feasibility of ultra high field 7.0 Tesla MR Spectroscopy for monitoring neo-adjuvant therapy efficacyneoadjuvant therapyborstkankerneo-adjuvante therapybreast cancerNL-OMON25351MC Utrecht15
已完成
不适用
Feasibility of ultra high field 7.0 Tesla MRI for the detection of breast cancerbreast neoplasm10006291breast cancerNL-OMON34075niversitair Medisch Centrum Utrecht20
已完成
不适用
Feasibility of ultra high field 7.0 Tesla MRIfor the detection of breast cancer.Breast tumorBreast neoplasmNL-OMON20303niversity Medical Center Utrecht (UMCU)Visiting address-----------------------Heidelberglaan 1003584 CX UtrechtThe NetherlandsPostal address---------------------Room E01.132PO Box 855003508 GA UtrechtThe NetherlandsPhone: +31 (0)88 75 555 5520
进行中（未招募）
1 期
ltra high field 7.0 Tesla MR Spectroscopy to monitor capecitabine metabolism in liver metastases – a proof of concept studyColorectal carcinomaMedDRA version: 19.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864EUCTR2016-000092-24-NLniversity Medical Center Utrecht